Intercept Pharmaceuticals Inc Preço/Valor Contábil
Qual é o Preço/Valor Contábil de Intercept Pharmaceuticals Inc?
O Preço/Valor Contábil de Intercept Pharmaceuticals Inc é 4.95
Qual é a definição de Preço/Valor Contábil?
A razão entre cotação e valor contabilístico representa a razão entre o valor das ações de uma empresa e o valor contábil por ação.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Preço/Valor Contábil de empresas na Setor Health Care em NASDAQ em comparação com Intercept Pharmaceuticals Inc
O que Intercept Pharmaceuticals Inc faz?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Empresas com preço/valor contábil semelhantes a Intercept Pharmaceuticals Inc
- HKE tem Preço/Valor Contábil de 4.94
- VanEck Vectors Gold Miners UCITS ETF tem Preço/Valor Contábil de 4.95
- Harrow Health tem Preço/Valor Contábil de 4.95
- Pan Pacific International tem Preço/Valor Contábil de 4.95
- Dolly Varden Silver tem Preço/Valor Contábil de 4.95
- Constellation Brands tem Preço/Valor Contábil de 4.95
- Intercept Pharmaceuticals Inc tem Preço/Valor Contábil de 4.95
- Nestlé SA tem Preço/Valor Contábil de 4.95
- Info Edge (India) tem Preço/Valor Contábil de 4.95
- Kewal Kiran Clothing tem Preço/Valor Contábil de 4.96
- Omai Gold Mines Corp tem Preço/Valor Contábil de 4.96
- Fuse Cobalt Inc tem Preço/Valor Contábil de 4.96
- Sheela Foam tem Preço/Valor Contábil de 4.96